Bushkin G Guy, Ratner Daniel M, Cui Jike, Banerjee Sulagna, Duraisingh Manoj T, Jennings Cameron V, Dvorin Jeffrey D, Gubbels Marc-Jan, Robertson Seth D, Steffen Martin, O'Keefe Barry R, Robbins Phillips W, Samuelson John
Department of Molecular and Cell Biology, Boston University Goldman School of Dental Medicine, Boston, MA 02118, USA.
Eukaryot Cell. 2010 Feb;9(2):228-41. doi: 10.1128/EC.00197-09. Epub 2009 Sep 25.
We are interested in asparagine-linked glycans (N-glycans) of Plasmodium falciparum and Toxoplasma gondii, because their N-glycan structures have been controversial and because we hypothesize that there might be selection against N-glycans in nucleus-encoded proteins that must pass through the endoplasmic reticulum (ER) prior to threading into the apicoplast. In support of our hypothesis, we observed the following. First, in protists with apicoplasts, there is extensive secondary loss of Alg enzymes that make lipid-linked precursors to N-glycans. Theileria makes no N-glycans, and Plasmodium makes a severely truncated N-glycan precursor composed of one or two GlcNAc residues. Second, secreted proteins of Toxoplasma, which uses its own 10-sugar precursor (Glc(3)Man(5)GlcNAc(2)) and the host 14-sugar precursor (Glc(3)Man(9)GlcNAc(2)) to make N-glycans, have very few sites for N glycosylation, and there is additional selection against N-glycan sites in its apicoplast-targeted proteins. Third, while the GlcNAc-binding Griffonia simplicifolia lectin II labels ER, rhoptries, and surface of plasmodia, there is no apicoplast labeling. Similarly, the antiretroviral lectin cyanovirin-N, which binds to N-glycans of Toxoplasma, labels ER and rhoptries, but there is no apicoplast labeling. We conclude that possible selection against N-glycans in protists with apicoplasts occurs by eliminating N-glycans (Theileria), reducing their length (Plasmodium), or reducing the number of N-glycan sites (Toxoplasma). In addition, occupation of N-glycan sites is markedly reduced in apicoplast proteins versus some secretory proteins in both Plasmodium and Toxoplasma.
我们对恶性疟原虫和刚地弓形虫的天冬酰胺连接聚糖(N -聚糖)感兴趣,因为它们的N -聚糖结构一直存在争议,而且我们推测,对于必须在内质网(ER)中穿过然后进入顶质体的核编码蛋白中的N -聚糖,可能存在选择作用。为支持我们的假设,我们观察到以下几点。首先,在具有顶质体的原生生物中,合成N -聚糖脂质连接前体的Alg酶大量次生缺失。泰勒虫不产生N -聚糖,疟原虫产生由一两个GlcNAc残基组成的严重截短的N -聚糖前体。其次,刚地弓形虫利用自身的10糖前体(Glc(3)Man(5)GlcNAc(2))和宿主的14糖前体(Glc(3)Man(9)GlcNAc(2))来合成N -聚糖,其分泌蛋白的N -糖基化位点很少,并且在其靶向顶质体的蛋白中对N -聚糖位点还有额外的选择作用。第三,虽然结合GlcNAc的西非单叶豆凝集素II标记疟原虫的内质网、棒状体和表面,但没有顶质体标记。同样,与刚地弓形虫N -聚糖结合的抗逆转录病毒凝集素蓝绿菌素 - N标记内质网和棒状体,但没有顶质体标记。我们得出结论,在具有顶质体的原生生物中,对N -聚糖的可能选择作用是通过消除N -聚糖(泰勒虫)、缩短其长度(疟原虫)或减少N -聚糖位点数量(刚地弓形虫)来实现的。此外,与疟原虫和刚地弓形虫的一些分泌蛋白相比,顶质体蛋白中N -聚糖位点的占据明显减少。